Results 161 to 170 of about 2,909,809 (211)

Acute Coronary Syndrome in Essential Thrombocythemia and Polycythemia Vera. [PDF]

Heart Views
Kaddoura R, Ahmed D, Rudwan A, Elyas A, Yassin MA.   +4 more
europepmc   +1 more source

Progression of carotid plaque burden in patients with polycythemia vera and essential thrombocythemia. [PDF]

Blood Res
Kwon SS, Jeong SY, Lee MY, Kim KH, Lee N, Won JH, Yoon SY.   +6 more
europepmc   +1 more source

Analysis of CALR-mutated essential thrombocythemia as a distinct disease entity compared with JAK2 V617F-mutated and triple-negative patients. [PDF]

Turk J Med Sci
Aydin GS, Aksoy E, Yönal Hindilerden İ, Dağlar Aday A, Gültürk E, Nalçaci M, Hindilerden F.   +6 more
europepmc   +1 more source

Acute megakaryoblastic transformation of essential thrombocythemia

Haematologica, 1996
N Vianelli, S Baravelli, L Gugliotta
doaj  

Some of the next articles are maybe not open access.

Related searches:

Stroke in essential thrombocythemia

Journal of the Neurological Sciences, 2014
Our aim was to assess the incidence and the special characteristics of stroke, as a severe complication of patients diagnosed with essential thrombocythemia (ET).A retrospective analysis was carried out on 102 patients with ET enrolled and analyzed from the period between 1999 and 2012. Patients with one or more strokes were selected.
László Vécsei, Katalin Sas, Imelda Marton   +2 more
exaly   +4 more sources

Essential Thrombocythemia and Pregnancy

Leukemia and Lymphoma, 1996
A review of the literature disclosed 106 pregnancies (preg.) in 57 women with essential thrombocythemia (ET). The success rate (baby alive) was 57% (60 live births/106 preg.), the rate of miscarriage 43% (46 miscarriages/106 preg.). The most frequent complication was spontaneous abortion during the first trimester in 36% (38 abortions/106 preg.). Other
Martin Griesshammer, Hermann Heimpel, Thomas C Pearson   +2 more
exaly   +3 more sources

Essential Thrombocythemia

Seminars in Hematology, 2005
Significant progress in our understanding of the molecular pathogenesis of essential thrombocythemia (ET) and the other Philadelphia (Ph) chromosome-negative myeloproliferative disorders (MPDs) has recently been achieved. Unfortunately, the diagnosis of ET still relies on a set of exclusion criteria developed years ago, as recent advances have yet to ...
Guido, Finazzi, Claire, Harrison
openaire   +2 more sources

Management of Essential Thrombocythemia

Critical Reviews in Oncology/Hematology, 1999
3. Risk stratification of patients with ET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 258 3.1. Bleeding and thrombosis in ET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 258 3.2. Risk factors for major bleeding . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 259 3.3. Risk factors for thrombosis. .
T, Barbui, G, Finazzi
openaire   +2 more sources

Essential thrombocythaemia

Best Practice & Research Clinical Haematology, 2003
Essential thrombocythaemia is a myeloproliferative disorder that results from the transformation of a multipotent haematopoietic progenitor. Its diagnosis can be challenging and its optimal management has been controversial, largely because of a virtual absence of randomised trials.
Claire N, Harrison, Anthony R, Green
openaire   +3 more sources

Pharmacotherapy of essential thrombocythemia

Expert Opinion on Pharmacotherapy, 2008
The natural history of essential thrombocythemia is characterized by an increased incidence of thrombotic and hemorrhagic events and, in the long-term, a tendency for disease transformation to myelofibrosis or acute leukemia. Advanced age and a prior history of thrombosis are the major predictors of thrombotic complications.The aim of this study was to
Naseema, Gangat, Ayalew, Tefferi
openaire   +2 more sources